Ledipasvir And Sofosbuvir Tablet, Film Coated
Product Images NDC 72626-2601

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ledipasvir And Sofosbuvir (NDC 72626-2601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asegua Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ledipasvir 01)

FDA Label Image

Chemical Structure (Ledipasvir 02)

FDA Label Image

Principal Display Panel (14 Tablet Blister Pack Card Carton)

Principal Display Panel (14 Tablet Blister Pack Card Carton)
This is a medication called "Ledipasvir and Sofosbuvir". It comes in 90 mg/400 mg tablets and is taken once daily. The packaging contains two blister cards, and each card has 14 tablets. It is an authorized generic version of HarvoniĀ®. There is a warning to not cover the ALERT box with a pharmacy label and to find out about medicines that should not be taken with Ledipasvir and Sofosbuvir. The manufacturer is Asegua Therapeutics.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.